temozolomide has been researched along with Sezary Syndrome in 1 studies
Sezary Syndrome: A form of cutaneous T-cell lymphoma manifested by generalized exfoliative ERYTHRODERMA; PRURITUS; peripheral lymphadenopathy, and abnormal hyperchromatic mononuclear (cerebriform) cells in the skin, LYMPH NODES, and peripheral blood (Sezary cells).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases." | 6.76 | Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. ( Baron, J; Dolan, ME; Foss, F; Guitart, J; Kuzel, TM; Pezen, DS; Querfeld, C; Rademaker, A; Rosen, ST; Yarosh, DB, 2011) |
| "Temozolomide (TMZ) is an oral derivative of dacarbazine that induces DNA damage by methylating nucleotide bases." | 2.76 | Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins. ( Baron, J; Dolan, ME; Foss, F; Guitart, J; Kuzel, TM; Pezen, DS; Querfeld, C; Rademaker, A; Rosen, ST; Yarosh, DB, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Querfeld, C | 1 |
| Rosen, ST | 1 |
| Guitart, J | 1 |
| Rademaker, A | 1 |
| Pezen, DS | 1 |
| Dolan, ME | 1 |
| Baron, J | 1 |
| Yarosh, DB | 1 |
| Foss, F | 1 |
| Kuzel, TM | 1 |
1 trial available for temozolomide and Sezary Syndrome
| Article | Year |
|---|---|
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylat | 2011 |